“You have to get the medicine from wherever in the world. You have to take steps right now. Wherever it is available in the world get it,” said a bench of Justices Vipin Sanghi and Jasmeet Singh which was assured by the Centre that it has already started taking steps to import the medicine. The court said the Centre should inform it about the steps taken to import the medicine, the shortfall of which was coming in the way of the treatment of this fungal infection which has been on the rise in the national capital and elsewhere in the country. The infection that affects the nose, eyes, sinuses, and sometimes even the brain is being detected among patients who are recovering or have recovered from COVID-19.
Central government standing counsel Kirtiman Singh and Amit Mahajan informed the court that as on May 19, there are 7,251 patients of black fungus in the country and this includes 200 in Delhi. Some states have also reported fatalities due to this disease with Maharashtra recording 90 deaths. The issue of shortage of the medicine for treating black fungus was raised by advocate Rakesh Malhotra.
Minister Mandaviya said the shortage of the anti-fungal drug will be resolved soon. “Black Fungus (Mucormycosis) curing drug #AmphotericinB’s shortage will be resolved soon! Within three days, 5 more Pharma companies have got New Drug Approval for producing it in India, in addition to the existing 6 pharma companies,” he said in a tweet.
Mandaviya, who is the Minister of State for Chemicals and Fertilizers, also said that existing pharma companies have already started ramping up the production of the drug. “Indian Companies have also placed orders for importing 6 lakh vials of #AmphotericinB. We are leaving no stone unturned to smoothen the situation,” he noted.
Error: No connected account.
Please go to the Instagram Feed settings page to connect an account.